Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bleyer

Showing results (141-150 of 664) with videos related to

Pageof 67
Sort By:
Drugs|March 11, 2000
Oral cancer chemotherapy in paediatric patients: obstacles and potential for development and utilisationW A Bleyer, M G Danielson
Nephron|July 9, 1999
Risk factors associated with hypertensive nephrosclerosisA J Bleyer, R G Appel
JAMA|September 21, 1970
Studies on the detection of adverse drug reactions in the newborn. II. The effects of prenatal aspirin on newborn hemostasisW A Bleyer, R T Breckenridge
Seminars in Oncology|October 20, 2009
The adolescence of young adult oncologyKaren Albritton, Ronald Barr, Archie Bleyer
Seminars in Oncology|August 1, 1996
Future development of amifostine in cancer treatmentD S Alberts, W A Bleyer
Cancer Drug Delivery|January 1, 1987
Management of infectious complications of intraventricular reservoirs in cancer patients: low incidence and successful treatment without reservoir removalP A Dinndorf, W A Bleyer
Pediatrics|June 12, 2014
Clinical trial enrollment among adolescents with cancer: supplement overviewEric Tai, Lynda Beaupin, Archie Bleyer
Journal of the National Medical Association|April 26, 2022
United States marijuana legalization and opioid mortality epidemic during 2010-2020 and pandemic implicationsArchie Bleyer, Brian Barnes, Kenneth Finn
Medecine Sciences : M/S|February 18, 2022
[Inhibition of anti-tumor immunity by NF-κB: Toward therapeutic targeting?]Lara Revol-Bauz, Yenkel Grinberg-Bleyer
The New England Journal of Medicine|June 18, 2004
Polycystic kidney diseaseAnthony J Bleyer, Thomas C Hart
Pageof 67

Showing results (141-150 of 664) with videos related to

Sort By:
Pageof 67
Drugs|March 11, 2000
Oral cancer chemotherapy in paediatric patients: obstacles and potential for development and utilisationW A Bleyer, M G Danielson
Nephron|July 9, 1999
Risk factors associated with hypertensive nephrosclerosisA J Bleyer, R G Appel
JAMA|September 21, 1970
Studies on the detection of adverse drug reactions in the newborn. II. The effects of prenatal aspirin on newborn hemostasisW A Bleyer, R T Breckenridge
Seminars in Oncology|October 20, 2009
The adolescence of young adult oncologyKaren Albritton, Ronald Barr, Archie Bleyer
Seminars in Oncology|August 1, 1996
Future development of amifostine in cancer treatmentD S Alberts, W A Bleyer
Cancer Drug Delivery|January 1, 1987
Management of infectious complications of intraventricular reservoirs in cancer patients: low incidence and successful treatment without reservoir removalP A Dinndorf, W A Bleyer
Pediatrics|June 12, 2014
Clinical trial enrollment among adolescents with cancer: supplement overviewEric Tai, Lynda Beaupin, Archie Bleyer
Journal of the National Medical Association|April 26, 2022
United States marijuana legalization and opioid mortality epidemic during 2010-2020 and pandemic implicationsArchie Bleyer, Brian Barnes, Kenneth Finn
Medecine Sciences : M/S|February 18, 2022
[Inhibition of anti-tumor immunity by NF-κB: Toward therapeutic targeting?]Lara Revol-Bauz, Yenkel Grinberg-Bleyer
The New England Journal of Medicine|June 18, 2004
Polycystic kidney diseaseAnthony J Bleyer, Thomas C Hart
Pageof 67